A.G. Schneiderman Announces $31 Million National Medicaid Settlement With Pharmaceutical Company
NEW YORK - Attorney General Eric T. Schneiderman today announced that New York State has joined with other states and the federal government to settle allegations that drug manufacturer Organon underpaid rebates to New York State's Medicaid program, offered improper financial incentives to nursing home pharmacy companies, promoted its antidepressants for unapproved uses, and misrepresented its drug prices to New York's Medicaid program. Organon was headquartered in Oss, Netherlands, and the company's assets are now owned by Merck. The total value of the settlement is $31 million. As part of the settlement, New York will receive $2,489,999 in restitution and other recoveries.
Action Details
- Date:October 15, 2014
- Agency:New York Attorney General
-
Enforcement Types:
- State Enforcement Agencies